Podcasts about aortic

Hey Heart Buddies! A heart murmur, congenital aneurysm of sinus of Valsalva, ruptured sinus of Valsalva into right ventricle, bicuspid aortic valve, persistent left superior vena cava and pacemaker... all in one extraordinary heart...This week, I talk with my friend, Dawn Anderson, about her extraordinary heart health journey. Living in Adrian, Minnesota, Dawn shares her experience of discovering and surviving a rare aortic aneurysm and bicuspid aortic valve at age 41. Despite facing multiple challenges, including depression and the stress of losing her job, Dawn emphasizes the importance of self-advocacy and seeking support. Her story highlights the necessity of listening to your body and staying informed about heart health. Dawn and I met through WomenHeart which is a non-profit providing education and support to female heart disease patients. Don't forget to subscribe!Join the Newsletter for almost weekly content for this podcast and other heart related news.Join the Patreon Community! The Joyful Beat zoom group is where you'll find connection and hope that you aren't alone in your journey.If you just want to support the show as a one-time gift (thank you), go here.**I am not a doctor and this is not medical advice. Be sure to check in with your care team about all the next right steps for you and your heart.**How to connect with BootsEmail: Boots@theheartchamberpodcast.comInstagram: @openheartsurgerywithboots or @boots.knightonLinkedIn: linkedin.com/in/boots-knightonBoots KnightonIf you enjoyed this episode, take a minute and share it with someone you know who will find value in it as well.

In this episode, Dr. Valentin Fuster summarizes the March 11, 2025 issue of the JACC, which features groundbreaking research on transcatheter aortic valve replacement (TAVR) and its expanding applications. The podcast delves into the latest studies on TAVR's impact on heart failure patients, the need for better patient selection, and how new findings are shaping the future of aortic stenosis treatment.

Transcatheter Aortic Valve Repair for Aortic Regurgitation with the Cusper Device

Are you curious about the origins and future of aortic root enlargement surgery? In this episode, our hosts discuss the surgical horizons of this underutilised technique. Featuring the well-respected Bo Yang, Can Gollmann-Tepeköylü and Miia L Lehtinen explore the creation of this innovative technique, as well as its reputation and utility in the surgical community. Listeners can expect to hear firsthand how Dr Yang discovered his esteemed procedure, as well as detailed comparisons to similar interventions and how patient suitability is assessed.

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241296669

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241300881

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241296675

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241296390

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241296370

This week we review a work from the department of cardiology and department of cardiac surgery at Boston Children's Hospital on late hypertension in patients following coarctation repair. Late hypertension has been associated previously with late transverse aortic arch Z score but can this be predicted by the immediate postoperative transverse aortic arch Z score also? What factors account for late hypertension in the coarctation patient? Should more patients have their aorta repaired from a sternotomy? Dr. Sanam Safi-Rasmussen, who is a PhD candidate at Copenhagen University, shares her insights from a work she performed while a research fellow at Boston Children's Hospital. DOI: 10.1016/j.jtcvs.2024.08.049

The POPular PAUSE TAVI trial investigated whether continuing or interrupting oral anticoagulation during transcatheter aortic valve implantation (TAVI) affected clinical outcomes. The randomized, open-label, noninferiority study included 858 patients and assessed a composite primary outcome of cardiovascular death, stroke, myocardial infarction, major vascular complications, or major bleeding at 30 days. The trial found that continuation was not noninferior to interruption, with higher bleeding risk but no significant difference in thromboembolic events, supporting interruption of anticoagulation in high-bleeding-risk TAVI patients.

Advisory Board experts Natalie Trebes and Max Hakanson rejoin host Abby Burns for part two of our conversation digging into the trends and challenges healthcare leaders need to pay attention to in 2025. Last week, our experts covered evolving power dynamics around network design, drug cost/spend, and cyber threats. This week, the group shifts their attention to unpack what's happening with our core care delivery infrastructure. What is the state of health systems—and what's in store for them? They also tackle the elephant in the room: how should leaders be thinking about the policy landscape as we enter a new administration? Links: Ep. 235: What CEOs need to know in 2025 (Part 1) Ep. 231: Big deal, little deal, or no deal? A 2024 health policy retrospective The state of the industry: What healthcare leaders need to know for 2025 Optum Advisory: Healthcare consulting services Aortic stenosis is vastly undertreated: Know how to identify and address it A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

A 27-year-old woman presents as a new patient to your practice.  She is without chief complaint. She asks to, “get a refill on my birth control pills” , having used combined oral contraceptives for the past 12 years without adverse effects.  Social history reveals she is a nonsmoker, without recreational drug use, drinks approximately 1-2 mixed drinks per week, and runs 2-3 miles 5 days a week with reported excellent activity tolerance. Her health history is generally unremarkable, but with patient report of a “mild heart murmur that was picked up when I was a teenager during a physical I needed so I could run track. I was told not to worry about it.” Physical exam is unremarkable with the exception of a mid-systolic click followed by a grade II mid to late systolic murmur without radiation. The remainder of the cardiac exam is within normal limits.  These findings most likely represent which type of murmur? A. PhysiologicB. Aortic stenosis C. Mitral regurgitation D. Mitral valve prolapse---YouTube: https://www.youtube.com/watch?v=wmGI7v_DPMY&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=105Visit fhea.com to learn more!

Interview with Callistus Ditah, MD

Internal manual aortic compression is a procedure that may be used intraoperatively in the management of massive pelvic bleeding. But what about EXTERNAL aortic compression? In February's 2025 AJOG (Grey Journal), under their Surgeon's Corner section, there will be a very nice video recap of an easy to adopt maneuver which may “buy time” in OB hemorrhage cases as surgical intervention is being planned. This is called the EAC maneuver. First described in 1994, this technique has regained the spotlight as rates of PPH have been on the rise. How is EAC done? Does it work? If so, why is this not part of the OB Hemorrhage bundle? Listen in for details.

Aortic Valve Prosthesis Selection   Guest: Kimberly Holst, M.D. Host: Sharonne Hayes, M.D.   In this podcast we will learn to identify patient specific factors to be considered during evaluation for aortic valve replacement including patient specific anatomy, comorbidities, and lifelong management of aortic valve disease. Learners will learn to identify advantages to mechanical and biologic prostheses for management of aortic valve disease and identify areas of developing technology and treatment options for aortic valve disease.   Topics Discussed: What are the main factors to consider when evaluating a patient for aortic valve replacement?  What patient specific factors that may make a patient less suitable for transcatheter aortic valve replacement (TAVR)? What are the advantages of each mechanical and biologic prostheses in treatment of aortic valve disease? What new technologies are available for management of aortic valve disease?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

In this interview, Drs. Scali and Spratt discuss how the historical norms are being challenged for connective tissue disease patients (CTD) and endovascular repair.

ACCESS TAVI: Randomized Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation

Thank you for joining us for our 2nd Cabral HouseCall of the weekend! I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks…   Valerie: Hi Doctor Cabral, I have a quick question I hope you can help with. I often make 32oz smoothie bowls and usually eat half. But sometimes I eat the whole thing, and I end up with upper stomach pain and a feeling like the smoothie is coming back up for the rest of the day. It goes away after a few hours, but my stomach feels stretched and sensitive for a few days afterward. This only happens when I eat large amounts of smoothie, not with other foods, so I think it's the quantity. Do you think something else could be going on? Thanks so much for your answer!     Angie: Hi Dr. Cabral,Thanks for your love for research in the health field. My husband was diagnosed with diabetes and wanting to help him naturally, I told him I would try out berberine and see if it gave me any reactions before he took it for diabetes. When I started taking it I noticed that I could tolerate more foods, like beans and other things that typically gave me a histamine reaction. It seemed to calm down my system. I would like to continue taking it so I can eat more foods without reactions, but I am hearing from the natural health community that it can kill off bifidobacteria. I only take one 500mg at lunch and one 500mg at dinner. My questions are 1. What does Berberine do that it allows me to eat more foods and 2. Is there any reputable research on long term use of Berberine?     Lenny: Thank you so much for all your hard work and for taking the time to answer our questions. I'm a big fan of post-workout smoothies, and my go-to recipe includes banana, spinach, broccoli, blueberries, avocado, dates, protein powder, cacao, chia and linseeds, creatine, ashwagandha, stevia, coconut, and cacao nibs. I do feel a bit bloated afterward, but it's the best way for me to get all these healthy ingredients in. What are your thoughts on this smoothie combination? If it's not optimal, do you have any suggestions for improvements? Thanks again for your help!      Christine: What Omega 3 gel caps do you recommend?     Gine: Hi Dr. Cabral - I am seeking guidance on how to manage my husbands dx of a biscupid aortic valve with anyeurism of ascending aorta. Both his parents of this but no anyeurism at 65. My husband is 41 and we found out 2 years ago his anyeurism was 4.8cm, then last year went down to 4.5cm, now this month back to 4.8cm. If this is accurate with the rate of growth they will inevitably rec. surgery which of course we want to avoid. Is there anything you'd recommend that could possibly reduce the size of anyeurism, prevent further growth and avoid surgery? I have him on DNS, omegas, vit D, berberine+, mag & probiotic. My son was born with the bicuspid as well and I want to make sure I do everything in my power to set him up for success and hopefully avoid ever having an anyeurism. TYSM!   Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right!   - - - Show Notes and Resources: StephenCabral.com/3236 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

In this podcast, Dr. Valentin Furster discusses a groundbreaking study on the role of oxidized phospholipids in calcific aortic valvular disease, highlighting their significant association with disease prevalence and progression. The findings suggest that targeting oxidized phospholipids, not just the Lp(a) particle, could offer a promising new therapeutic approach to treat this condition.

JACC Associate Editor Marc P. Bonaca, MD, FACC, has a discussion with author Sotirios Tsimikas, MD, FACC about this study on phospholipids presented at AHA and published in JACC. In MESA, both OxPL-apoB and Lp(a) were independently associated with prevalent AVC with a significant interaction between the two (p less than 0.01). OxPL-apoB and Lp(a) were associated with incident AVC at 9.5 years when evaluated independently (interaction p less than 0.01). The OxPL-apoB*Lp(a) interaction demonstrated higher odds of prevalent and incident AVC for OxPL-apoB with increasing Lp(a) levels. In the meta-analysis, both OxPL-apoB and Lp(a) were independently associated with faster increase in Vmax, but when evaluated together, only OxPL-apoB remained significant. OxPL-apoB is an independent predictor of the presence, incidence and progression of AVC and established AS and represents a novel therapeutic target for CAVD.

On the second November episode of JHLT: The Podcast, the Digital Media Editors continue MCS-month with a paper from the November issue of JHLT, entitled “Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on perioperative and postoperative assessment and management.”  First author Diyar Saeed, MD, PhD, of the Heart Center Niderrhein, and senior author Jennifer Cowger, MD, MS, of Henry Ford Hospitals both join the podcast. You'll hear about: Why LVAD patients develop new and progressive aortic regurgitation—and how contemporary devices may differ Associated hemodynamic events Intraoperative surgical techniques Slowing the progression of the condition and monitoring it post-op Early interventions For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. If you haven't yet tuned in for the first November episode of the podcast, MCS enthusiasts will be happy to know the paper discusses temporary MCS devices in acute RV failure. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.  

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.  This episode covers: Cardiology This Week: A concise summary of recent studies Aortic aneurysms Return to elite sports after a severe cardiac event Milestones: CAST Host: Emer Joyce Guests: Carlos Aguiar, Jose Rodriguez Palomares, Harald Jorstad Want to watch that episode? Go to: https://esc365.escardio.org/event/1795 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Emer Joyce, Nicolle Kraenkel and Jose Rodriguez Palomares have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo. Harald Jorstad has declared to have potential conflicts of interest to report: unrestricted research grants to institution: Dutch Olympic Committee, Dutch Heart Foundation, Zon-Mw, Heart to Handle. Unrestricted, unrelated research grants to institution: Novartis, Amarin, Novo Nordisk, Sanofi. Unrelated advisory fees to institution: Amarin, Amgen. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode delves into the pressing need to reevaluate the management strategies for Aortic Valve Disease (AVD) worldwide. With a focus on South Asian and Sub-Saharan African nations, the discussion highlights how low-income countries predominantly rely on surgical aortic valve replacement (SAVR) using mechanical valves. The episode explores the unique challenges faced in these regions, where patients are generally younger compared to those in high-income countries, and the disease often stems from rheumatic origins. The conversation aims to shed light on the disparities in treatment approaches and the necessity for tailored solutions that address the distinct characteristics of AVD in diverse global contexts.

This episode delves into a lesser-known yet critical heart condition that affects millions, particularly older adults. Dr. Kota Reddy breaks down the condition's causes, symptoms, and its significant link to cardiovascular risks like heart attacks and coronary artery disease. Through compelling patient stories, listeners will discover how lifestyle changes, such as diet modifications and regular exercise, can slow or even halt progression, delaying the need for invasive procedures. With insights into diagnosis, risk factors, and prevention strategies, this episode equips listeners with practical tools to take charge of their heart health.

NOTION-3 – Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by cardiac surgeon Professor Marjan Jahangiri from St George's Hospital, London. They discuss how to manage this condition and how and why TAVI might be used. If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts - it's really helpful. Link to published paper: https://heart.bmj.com/content/110/22/1291   

Contributor: Aaron Lessen MD Educational Pearls: Aortic injury occurs in 1.5-2% of patients who sustain blunt thoracic trauma Majority are caused by automobile collisions or motorcycle accidents Due to sudden deceleration mechanism accidents Clinical manifestations Signs of hypovolemic shock including tachycardia and hypotension, though not always present Patients may have altered mental status Imaging Widened mediastinum on chest x-ray, though not highly sensitive CT is more sensitive and specific, and signs of thoracic injury include an intimal flap, aortic wall outpouching, and aortic contour abnormalities In hemodynamically unstable or otherwise unfit for CT patients, transesophageal echocardiogram may be used Four types of aortic injury (in order of ascending severity) I: Intimal tear or flap II: Intramural hematoma III: Pseudoaneurysm IV: Rupture Management Hemodynamically unstable: immediate OR for exploratory laparotomy and repair Hemodynamically stable: heart rate and blood pressure control with beta-blockers Minor injuries are treated with observation and hemodynamic control Severe injuries may receive surgical management Some patients benefit from delayed repair An endovascular aortic graft is a surgical option Mortality 80-85% of patients die before hospital arrival 50% of patients that make it to the hospital do not survive References Fox N, Schwartz D, Salazar JH, et al. Evaluation and management of blunt traumatic aortic injury: a practice management guideline from the Eastern Association for the Surgery of Trauma [published correction appears in J Trauma Acute Care Surg. 2015 Feb;78(2):447]. J Trauma Acute Care Surg. 2015;78(1):136-146. doi:10.1097/TA.0000000000000470 Lee WA, Matsumura JS, Mitchell RS, et al. Endovascular repair of traumatic thoracic aortic injury: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg. 2011;53(1):187-192. doi:10.1016/j.jvs.2010.08.027 Osgood MJ, Heck JM, Rellinger EJ, et al. Natural history of grade I-II blunt traumatic aortic injury. J Vasc Surg. 2014;59(2):334-341. doi:10.1016/j.jvs.2013.09.007 Osman A, Fong CP, Wahab SFA, Panebianco N, Teran F. Transesophageal Echocardiography at the Golden Hour: Identification of Blunt Traumatic Aortic Injuries in the Emergency Department. J Emerg Med. 2020;59(3):418-423. doi:10.1016/j.jemermed.2020.05.003 Steenburg SD, Ravenel JG, Ikonomidis JS, Schönholz C, Reeves S. Acute traumatic aortic injury: imaging evaluation and management. Radiology. 2008;248(3):748-762. doi:10.1148/radiol.2483071416 Summarized by Jorge Chalit, OMS3 | Edited by Meg Joyce & Jorge Chalit Donate: https://emergencymedicalminute.org/donate/  

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from October 26-November 1, 2024.

Aortic dissection is a dangerous condition of the heart and must be treated quickly and effectively to ensure survival. The Comprehensive Aortic Program, part of the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, is dedicated to the early detection, monitoring and treatment of various aortic diseases using evidence-based treatments.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on mortality burden for patients with untreated aortic regurgitation.

Salvatore Scali, MD, provides a contemporary perspective on aortic surgery training will be discussed highlighting current case volumes and future projections among training programs in the United States. The barriers to open aortic surgical training and potential opportunities that are available to offset these challenges longitudinally will be discussed.

25th ESC 2024: ESC 2024 PAAD Guideline

 Today we are discussing transcatheter aortic valve implantation, also known as TAVI.  TAVI that has become pivotal in the cardiology space since its introduction in 2002, and today we'll compare TAVI to surgical aortic valve replacement. We'll also discuss the importance of shared decision making.  This podcast is sponsored by Medtronic. The views expressed in this podcast are not necessarily those of Medtronic.  To learn more, we are joined by consultant cardiologists Dr Jason Sharp & Dr Dennis Wang from the Sydney Adventist Hospital to discuss some key updates in the TAVI space.

In this episode, Jian'an Wang discusses a study investigating the relationship between elevated serum lipoprotein A (LPA) levels and the risk of severe degenerative aortic stenosis in a cohort of 742 patients. The findings reveal a significant association, particularly with LPA levels exceeding 100 mg/dL, highlighting LPA's potential as a therapeutic target and underscoring the need for further research into therapies aimed at lowering LPA levels.

Date: September 23, 2024 Reference: Essat et al. Diagnostic Accuracy of D-Dimer for Acute Aortic Syndromes: Systematic Review and Meta-Analysis. Annals of Emergency Medicine, May 2024 Guest Skeptic: Dr. Casey Parker is a Rural Generalist from Australia who is also an ultrasounder. Case: You are working a busy shift in a rural emergency department (ED) […] The post SGEM#454: I Just Died in Your Arms Tonight – Diagnostic Accuracy of D-Dimer for Acute Aortic Syndromes first appeared on The Skeptics Guide to Emergency Medicine.

One-Year Efficacy and Safety of the Dry-Pericardium Aortic Valve: A First-in-Human Feasibility Study

Surgical Versus Transcatheter Approach in Combined Coronary and Aortic Valve Disease

First TAVI vs. SAVR Randomized Trial in Younger Low-Risk Patients with Severe Tricuspid or Bicuspid Aortic Valve Stenosis: Results from NOTION-2

In the September 17, 2024 issue of JACC, Dr. Jai Quan Song and colleagues explore whether the DPP-4 inhibitor, abrogating, can slow the progression of aortic valvular calcification. Although the primary endpoint was not met, the study's promising secondary results and ongoing research into related therapies suggest potential future breakthroughs in medical treatment for aortic stenosis.

In this episode, we discuss the challenges of explanting aortic grafts, the diagnosis and management of infected aortic grafts, as well as tips and tricks for once we're in the operating room.   Interviewers/Editors: Mark Basilious, MD Candidate (@markrbasilious) Eva Urrechaga, MD (@urrechisme) Sharif Ellozy, MD (@SharifEllozy)   Guests: Dr. Francis Caputo (@FrankCaputoMD) is an Associate Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, Vascular Surgery Director of the Aorta Center, and Program Director of the Vascular Surgery Training Programs. His clinical interests include complex open and endovascular repair of thoracic, thoracoabdominal, and abdominal aortic aneurysms, management of thoracic dissection, and endovascular and open repair of failed endograft. Dr. Caputo earned his medical degree from the University of Medicine and Dentistry New Jersey, Newark, NJ, where he also served his surgical residency and two years as a National Institutes of Health research fellow. He completed his fellowship in vascular surgery at Barnes-Jewish Hospital of Washington University, St. Louis, MO and joined the Cleveland Clinic medical staff in 2018.    Dr. Peter Rossi (@peterjrossi) is a Professor of Surgery, Radiology, and Orthopedic Surgery, and Chief of the Division of Vascular and Endovascular Surgery at the Medical College of Wisconsin. His primary research and clinical interests are in complex  “re-do” and revision surgery, including for thoracoabdominal and abdominal aortic aneurysms, carotid artery surgery, and renal and mesenteric arterial disease, as well as vascular reconstruction for complicated soft tissue sarcomas. Dr. Rossi completed medical school at the University of Illinois College of Medicine before completing his general surgery training at the University of Chicago and his vascular surgery training at the Medical College of Wisconsin, where he has been a member of the faculty since 2009.  Dr. Xavier Berard (@XavierBerardMD)  is a French vascular surgeon who has been a Consultant in the Department of Vascular Surgery and Professor of Vascular and Endovascular Surgery in Bordeaux University Hospital in Bordeaux, France since 2010 and a full Professor of Vascular Surgery at the University of Bordeaux since 2016. He has also completed a PhD in Vascular Biomaterials and in 2010 worked as a research fellow at Lausanne University Hospital in Switzerland. He has been board certified by the French College of Vascular and Endovascular Surgeons since 2008 and by the European Society for Vascular and Endovascular Surgery since 2010. He has served as an examiner for the FEBVS exam since 2014 and as a reviewer for the European Journal of Vascular and Endovascular Surgery since 2016. Additionally, he is a member of the ESVS guidelines writing group for vascular graft infection and AAA.  His personal surgical interests include open surgery of (thoraco)abdominal aneurysms, redo aortic surgery, infections in vascular surgery, EVAR explantation, and biomaterials. He works closely with Institut Bergonié Bordeaux Cancer Center for sarcomas. You can see educational videos and learn more about Dr. Xavier Berard here. Helpful links and resources: Video of explantation of infected chimney EVAR with duodenal fistula (courtesy of Dr. Berard) Video of reimplanting the IMA after explanting an infected graft Video of explantation of infected graft with suprarenal fixation Videos of using the syringe technique to remove an aortic stent graft here and here (courtesy of Dr. Berard) References Kim YW. Aortic Endograft Infection: Diagnosis and Management. Vasc Specialist Int. 2023 Sep 21;39:26. doi: 10.5758/vsi.230071. PMID: 37732343; PMCID: PMC10512004. Papas TT. Patient Selection Is Essential for Explantation of Infected Abdominal Aortic Endografts. Angiology. 2023 Nov 23:33197231218622. doi: 10.1177/00033197231218622. Epub ahead of print. PMID: 37995099. Anagnostopoulos A, Mayer F, Ledergerber B, Bergadà-Pijuan J, Husmann L, Mestres CA, Rancic Z, Hasse B; VASGRA Cohort Study. Editor's Choice - Validation of the Management of Aortic Graft Infection Collaboration (MAGIC) Criteria for the Diagnosis of Vascular Graft/Endograft Infection: Results from the Prospective Vascular Graft Cohort Study. Eur J Vasc Endovasc Surg. 2021 Aug;62(2):251-257. doi: 10.1016/j.ejvs.2021.05.010. Epub 2021 Jun 14. PMID: 34140225. Lumsden AB. Explant of the Aortic Endograft: Today's Solutions, Tomorrow's Problems. Methodist Debakey Cardiovasc J. 2023 Mar 7;19(2):38-48. doi: 10.14797/mdcvj.1176. PMID: 36936357; PMCID: PMC10022536. Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

Comparison of Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valves: 1-Year Outcomes

Dr. Valentin Fuster discusses the treatment and diagnosis of transcatheter aortic valve thrombosis, focusing on its manifestations, diagnostic techniques using multi-slice computed tomography, and a proposed treatment algorithm. It highlights the difference between subclinical and clinical thrombosis and provides a detailed approach to managing both, including antiplatelet and anticoagulant therapies.

To have your question featured in a future video, please email: questions@drmdc.health

In this episode of the Heart podcast, Digital Media Editor, Professor James Rudd, is joined by Professor Marc Dweck from The University of Edinburgh. They discuss a study in Heart that tested the predictive power of thoracic aortic calcium calcium for predicting future vascular events. Relevant reading: Thoracic versus coronary calcification for atherosclerotic cardiovascular disease events prediction - https://heart.bmj.com/content/110/14/947  Editorial: Future applications of incidental detection of thoracic and coronary calcium for atherosclerotic cardiovascular disease events prediction - https://heart.bmj.com/content/110/14/929 If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2 or wherever you get your podcasts - it's really helpful.

Welcome to the emDOCs.net podcast! Join us as we review our high-yield posts from our website emDOCs.net. Today on the emDOCs cast, Jess Pelletier and Brit Long cover acute aortic occlusion. To continue to make this a worthwhile podcast for you to listen to, we appreciate any feedback and comments you may have for us. Please let us know!Subscribe to the podcast on one of the many platforms below:Apple iTunesSpotifyGoogle Play

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

Building a Bridge Between Two Worlds with Aaron Kendle In this riveting episode, we dive deep into the extraordinary journey of Aaron Kendle, who dedicated 16 years to the Navy SEALs, completing six deployments. Kendle began his career as a medic, advanced to become a sniper, and eventually served as a sky-diving instructor for the West Coast SEALs in San Diego. Transitioning from military to civilian life, Kendle embraced a new mission as the CEO of the SEAL Future Fund (SFF), an organization devoted to helping fellow SEALs transition into civilian life and careers, with the creation of tailored resumes, professional coaching, and networking opportunities. Despite a devastating accident that required hand amputation and the discovery and treatment of his life-threatening aortic aneurysm, Aaron proves firsthand that perspective, attitude and determination go a long way in life. Tune in to hear Aaron Kendle's full story and gain valuable insights on leadership, resilience, and the power of community in supporting life transitions. In this episode you will hear: • Q: So what was it that made you want to become a Navy SEAL? A: I started thinking about it before I graduated. 9-11 is what shifted my path. (7:37) • I still going to the VFW. I still love talking to those older guys. It's a different mindset. (11:14) • I heard my name going to Gold Team. As the classes get smaller and smaller, the guys get tighter. (44:33) • We were living in Morgan's house. Every Wednesday, if we were all together, we would go to Outback Steakhouse and get Chocolate Thunder. (50:48) • Aaron speaks about “Extortion,” when 30 servicemen were killed when a Chinook helicopter was shot down in Afghanistan. (57:25) • 2 days later when everything opened up, I remember calling my dad on a sat phone, saying “Hey, it's me. I'm alive. I'd love to stay and chat, but there's a bunch of stuff going on.” (61:59) • The older guys that did 20-30 years. Those are the guys trying to figure out what's the next step? (81:13) • Aaron tells the most ridiculous and compelling story of an accident that resulted in having his hand amputated, and the subsequent hilarious events that followed. (82:12) • “You have an Aortic aneurism. Your Aorta is way oversized.” (98:09) During Covid I'm out there skateboarding. Made this turn, hit a wet patch, and landed directly on my nub. (103:35) • I had a seizure. Out of nowhere. (104:18) If I don't have a goal for something, then I'm not doing anything. (109:16) • Starting running is the worst feeling of all time. To stand there and then begin to run is terrible. (110:13) • I think I owe it to people. 1 - I'm not dead. If I can go out there and suffer a little bit to help motivate people, and make ‘em better than I am, that's our goal. (123:23)  Socials: -  IG: redmanda252 -  IG: team_neverquit , marcusluttrell , melanieluttrell , huntero13 - https://www.patreon.com/teamneverquit Sponsors:   - Navyfederal.org          - drinkAG1.com/TNQ   - PXG.com/TNQ   - Shadyrays.com [TNQ]   - Hims.com/TNQ    - Shopify.com/TNQ   - mackweldon.com/utm_source=streaming&utm_medium=podcast&utm_campaign=podcastlaunch&utm_content=TNQutm_term=TNQ   - ghostbed.com/TNQ [TNQ]   - Aura.com/TNQ   - Moink.com/TNQ   - TAKELEAN.com [TNQ]   - usejoymode.com [TNQ]   - Shhtape.com [TNQ]   - Policygenius.com